A major breakthrough in brain research has earned three scientists the 2026 Nobel Prize in Physiology or Medicine. Their work led to the creation of a powerful tool called optogenetics, which allows scientists to control individual brain cells using light. The prize was awarded to Dr. Karl Deisseroth from Stanford University in the U.S., and Dr. Peter Hegemann and Dr. Georg Nagel from Humboldt University of Berlin and the University of Würzburg in Germany, respectively.
Optogenetics works by using light to activate or deactivate specific brain cells, much like flipping a switch. This method has opened up entirely new possibilities for studying how the brain works, allowing researchers to map brain circuits with unprecedented precision. Previously, such detailed brain mapping was only a dream.
The discovery began in 2000 when Dr. Hegemann and Dr. Nagel found a light-sensitive protein called channelrhodopsin in a type of single-celled algae. Later, Dr. Deisseroth adapted this protein so that it could be used to control nerve cells in rats by shining blue light on them. When the light hits these modified cells, it opens tiny channels, allowing electrically charged particles to flow in or out. This creates electrical signals in the cells, similar to how natural brain activity works.
This technology has already shown great promise in medical research. For example, scientists are exploring how optogenetics might help restore vision in people with eye diseases like retinitis pigmentosa or Stargardt disease, which cause progressive vision loss. One company, Nanoscope Therapeutics, is testing a gene therapy called Mogenry (sonpiretigene isteparvovec) that uses optogenetics to treat retinal diseases. Early results from a Phase II study on people with Stargardt disease—a genetic eye condition—have been encouraging. The company plans to share results from a larger Phase III study in 2027.
Beyond vision restoration, optogenetics could also lead to better treatments for brain injuries, strokes, depression, and addiction. By studying how specific brain cells influence behavior, memory, and emotions, researchers hope to develop more targeted and effective therapies for these conditions.